Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ERCC6 ERCC6L RSF1 CHD2 CHD7	5.78e-07	37	88	5	GO:0140658
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	WAPL ERCC6 ERCC6L RSF1 CHD2 CHD7 TOP2B	1.48e-06	127	88	7	GO:0008094
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine N-sulfotransferase activity	NDST3 NDST4	1.15e-04	4	88	2	GO:0015016
GeneOntologyMolecularFunction	N-acetylglucosamine deacetylase activity	NDST3 NDST4	1.15e-04	4	88	2	GO:0050119
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	WAPL ERCC6 ERCC6L RSF1 CHD2 CHD7 TOP2B	1.59e-04	262	88	7	GO:0140097
GeneOntologyMolecularFunction	protein kinase A regulatory subunit binding	PRKACA PRKACG RYR2	1.77e-04	25	88	3	GO:0034237
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACA PRKACG	3.97e-04	7	88	2	GO:0004691
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACA PRKACG	6.78e-04	9	88	2	GO:0004690
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACA PRKACG	8.44e-04	10	88	2	GO:0004679
GeneOntologyMolecularFunction	histone binding	PWP1 RSF1 ANP32A CHD2 CHD7 KDM1B	1.13e-03	265	88	6	GO:0042393
GeneOntologyMolecularFunction	ATP-dependent activity	ABCF1 WAPL ERCC6 ERCC6L RSF1 CHD2 CHD7 TOP2B HSP90AB3P	1.53e-03	614	88	9	GO:0140657
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	NDST3 NDST4	1.94e-03	15	88	2	GO:0034483
GeneOntologyMolecularFunction	beta-catenin binding	AMER2 CDH2 CDH11 CDH18	1.96e-03	120	88	4	GO:0008013
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	WAPL ERCC6 TYW1B ERCC6L RSF1 POLR2H CHD2 CHD7 TOP2B	2.14e-03	645	88	9	GO:0140640
GeneOntologyMolecularFunction	protein kinase A binding	PRKACA PRKACG RYR2	2.14e-03	58	88	3	GO:0051018
Domain	SNF2_N	ERCC6 ERCC6L CHD2 CHD7	1.43e-05	32	87	4	IPR000330
Domain	SNF2_N	ERCC6 ERCC6L CHD2 CHD7	1.43e-05	32	87	4	PF00176
Domain	AFAP	AFAP1 AFAP1L2	6.42e-05	3	87	2	IPR030113
Domain	Neurofascin/L1/NrCAM_C	NRCAM NFASC	1.28e-04	4	87	2	IPR026966
Domain	Bravo_FIGEY	NRCAM NFASC	1.28e-04	4	87	2	PF13882
Domain	HSNSD	NDST3 NDST4	1.28e-04	4	87	2	PF12062
Domain	Heparan_SO4_deacetylase	NDST3 NDST4	1.28e-04	4	87	2	IPR021930
Domain	Cadherin_cytoplasmic-dom	CDH2 CDH11 CDH18	2.08e-04	25	87	3	IPR000233
Domain	Cadherin_C	CDH2 CDH11 CDH18	2.08e-04	25	87	3	PF01049
Domain	IRO	IRX1 IRX4	3.18e-04	6	87	2	SM00548
Domain	Iroquois_homeo	IRX1 IRX4	3.18e-04	6	87	2	IPR003893
Domain	Catenin_binding_dom	CDH2 CDH11 CDH18	3.27e-04	29	87	3	IPR027397
Domain	-	CDH2 CDH11 CDH18	3.27e-04	29	87	3	4.10.900.10
Domain	Helicase_C	ERCC6 ERCC6L CHD2 CHD7	1.57e-03	107	87	4	PF00271
Domain	HELICc	ERCC6 ERCC6L CHD2 CHD7	1.57e-03	107	87	4	SM00490
Domain	Helicase_C	ERCC6 ERCC6L CHD2 CHD7	1.63e-03	108	87	4	IPR001650
Domain	HELICASE_CTER	ERCC6 ERCC6L CHD2 CHD7	1.68e-03	109	87	4	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC6 ERCC6L CHD2 CHD7	1.68e-03	109	87	4	PS51192
Domain	DEXDc	ERCC6 ERCC6L CHD2 CHD7	1.68e-03	109	87	4	SM00487
Domain	Helicase_ATP-bd	ERCC6 ERCC6L CHD2 CHD7	1.74e-03	110	87	4	IPR014001
Domain	Homeobox_KN	IRX1 IRX4	2.79e-03	17	87	2	PF05920
Domain	Homeobox_KN_domain	IRX1 IRX4	2.79e-03	17	87	2	IPR008422
Domain	PH	AFAP1 AFAP1L2 RASA1 SH3BP2 SKAP2	4.34e-03	229	87	5	PF00169
Domain	Chromo_domain	CHD2 CHD7	5.54e-03	24	87	2	IPR023780
Domain	Chromo	CHD2 CHD7	6.48e-03	26	87	2	PF00385
Domain	CHROMO_1	CHD2 CHD7	7.49e-03	28	87	2	PS00598
Domain	CHROMO_2	CHD2 CHD7	7.49e-03	28	87	2	PS50013
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	NECTIN1 CDH2 CDH11 CDH18	3.53e-05	40	66	4	MM15060
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	NECTIN1 CDH2 CDH11 CDH18	7.30e-05	48	66	4	MM15069
Pathway	REACTOME_CELL_CELL_COMMUNICATION	NECTIN1 SKAP2 CDH2 CDH11 CDH18	8.49e-05	96	66	5	MM14592
Pathway	WP_HIPPO_SIGNALING_REGULATION	PRKACA PRKACG CDH2 CDH11 CDH18	9.36e-05	98	66	5	M39830
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	NECTIN1 CDH2 CDH11 CDH18	1.54e-04	58	66	4	M11980
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACG	2.14e-04	5	66	2	M26988
Pathway	WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	PRKACA PRKACG CDH2 CDH11 CDH18	2.52e-04	121	66	5	M39823
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	NECTIN1 CDH2 CDH11 CDH18	3.74e-04	73	66	4	MM15126
Pathway	REACTOME_NEUROFASCIN_INTERACTIONS	NRCAM NFASC	4.47e-04	7	66	2	M27380
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACG	4.47e-04	7	66	2	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACG	5.94e-04	8	66	2	M27840
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACA PRKACG	7.61e-04	9	66	2	M27877
Pathway	REACTOME_CELL_CELL_COMMUNICATION	NECTIN1 SKAP2 CDH2 CDH11 CDH18	7.85e-04	155	66	5	M522
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	NECTIN1 CDH2 CDH11 CDH18	8.28e-04	90	66	4	M820
Pathway	KEGG_DILATED_CARDIOMYOPATHY	CACNA1D PRKACA PRKACG RYR2	8.28e-04	90	66	4	M835
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	PWP1 PRPF31 ABCF1 AFAP1 MAP1B USP42 CD2BP2 POLR2H NUCKS1 HIC2 CHD2 CHD7 KDM1B FLG2 HNRNPLL GTF3C5 TOP2B	1.95e-09	1082	89	17	38697112
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PRPF31 WAPL HIVEP1 ERCC6 CFDP1 RSF1 CHD2 CHD7 KDM1B MCM10 GTF3C5 TOP2B	5.10e-08	608	89	12	36089195
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	PWP1 AMER2 ABCF1 WAPL AFAP1 MAP1B PRKACA NUCKS1	2.41e-07	246	89	8	15345747
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	PRPF31 WAPL CD2BP2 CFDP1 RSF1 POLR2H ANP32A NUCKS1 CHD2 KDM1B VIRMA HNRNPLL GTF3C5 TOP2B	2.94e-07	1014	89	14	32416067
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD IL16 ZNF609 WAPL ERCC6 SV2A SH3BP2 SAP30BP RSF1 MTR HIC2 KDM1B CLSPN SNAP29	9.19e-07	1116	89	14	31753913
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PRPF31 ZNF609 WAPL ERCC6L MTR NUCKS1 CHD7 MCM10 CLSPN REEP3 GTF3C5	2.78e-06	733	89	11	34672954
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ZBTB48 USP42 SAP30BP RSF1 PARD3B CHD2 CHD7 GTF3C5 TOP2B	3.34e-06	469	89	9	27634302
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	PRKACA PRKACG RYR2	3.50e-06	12	89	3	10830164
Pubmed	The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.	CD19 PRKACA PRKACG	4.55e-06	13	89	3	20402410
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PWP1 ABCF1 WAPL HIVEP1 USP42 ERCC6L EML4 NUCKS1 CHD7 VIRMA TOP2B	4.67e-06	774	89	11	15302935
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PWP1 PRPF31 ABCF1 AFAP1 ERCC6 PPP1R9A SAP30BP POLR2H PRKACA SPIRE1 CHD2 CHD7 KDM1B VIRMA HNRNPLL	5.73e-06	1497	89	15	31527615
Pubmed	Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes.	CACNA1D RYR2	6.48e-06	2	89	2	33034621
Pubmed	Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release.	PRKACA RYR2	6.48e-06	2	89	2	17693412
Pubmed	KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression.	ARHGAP30 VIRMA	6.48e-06	2	89	2	38717936
Pubmed	Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.	PRKACA RYR2	6.48e-06	2	89	2	23507255
Pubmed	Characterization of the cAMP-dependent protein kinase catalytic subunit Cgamma expressed and purified from sf9 cells.	PRKACA PRKACG	6.48e-06	2	89	2	15039079
Pubmed	Neurofascin induces neurites by heterophilic interactions with axonal NrCAM while NrCAM requires F11 on the axonal surface to extend neurites.	NRCAM NFASC	6.48e-06	2	89	2	8922386
Pubmed	Cadherin-11 expressed in association with mesenchymal morphogenesis in the head, somite, and limb bud of early mouse embryos.	CDH2 CDH11	6.48e-06	2	89	2	7750650
Pubmed	CDH2 and CDH11 act as regulators of stem cell fate decisions.	CDH2 CDH11	6.48e-06	2	89	2	25771201
Pubmed	N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms.	CDH2 CDH11	6.48e-06	2	89	2	20605916
Pubmed	Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage.	CDH2 CDH11	6.48e-06	2	89	2	15476585
Pubmed	Chondroitin sulfate-E fine-tunes osteoblast differentiation via ERK1/2, Smad3 and Smad1/5/8 signaling by binding to N-cadherin and cadherin-11.	CDH2 CDH11	6.48e-06	2	89	2	22440395
Pubmed	The Cardiac Ryanodine Receptor Phosphorylation Hotspot Embraces PKA in a Phosphorylation-Dependent Manner.	PRKACA RYR2	6.48e-06	2	89	2	31078384
Pubmed	Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes.	CDH2 CDH11	6.48e-06	2	89	2	18383368
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD AMER2 ABCF1 NRCAM MAP1B COPG1 SV2A NECTIN1 ANP32A PRICKLE2 HNRNPLL RYR2 SNAP29	6.53e-06	1139	89	13	36417873
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PWP1 ZNF609 ABCF1 WAPL NRDC MAP1B ERCC6L EML4 MTR CLSPN	6.55e-06	650	89	10	38777146
Pubmed	Differential Spatiotemporal Expression of Type I and Type II Cadherins Associated With the Segmentation of the Central Nervous System and Formation of Brain Nuclei in the Developing Mouse.	CDH2 CDH11 CDH18	7.21e-06	15	89	3	33833667
Pubmed	Trio controls the mature organization of neuronal clusters in the hindbrain.	NRCAM CDH2 CDH11	7.21e-06	15	89	3	17898204
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PRPF31 ABCF1 WAPL ERCC6 MAP1B COPG1 EML4 RSF1 POLR2H CHD2 CHD7 MCM10 GTF3C5 TOP2B	8.49e-06	1353	89	14	29467282
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CYLD PRPF31 ABCF1 COPG1 ERCC6L SH3BP2 PRKACA PJA1 CLSPN SOX13 GTF3C5 SNAP29	1.35e-05	1038	89	12	26673895
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PWP1 PRPF31 ABCF1 WAPL HIVEP1 NRDC COPG1 ANP32A PRKACA MTR NUCKS1 HNRNPLL GTF3C5 TOP2B	1.52e-05	1425	89	14	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IL16 ABCF1 AFAP1 NRCAM NRDC MAP1B SV2A PPP1R9A PRKACA PRICKLE2 NFASC SPIRE1 CDH2 VIRMA	1.59e-05	1431	89	14	37142655
Pubmed	E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.	CDH2 CDH11 CDH18	1.79e-05	20	89	3	7806582
Pubmed	CircMAP3K4 Suppresses H2O2-Induced Human Lens Epithelial Cell Injury by miR-630/ERCC6 Axis in Age-Related Cataract.	ERCC6 MAP3K4	1.94e-05	3	89	2	38152055
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACG	1.94e-05	3	89	2	2342480
Pubmed	Suppression of Rad leads to arrhythmogenesis via PKA-mediated phosphorylation of ryanodine receptor activity in the heart.	PRKACA RYR2	1.94e-05	3	89	2	25193703
Pubmed	Ectodomain shedding of nectin-1 regulates the maintenance of dendritic spine density.	NECTIN1 CDH2	1.94e-05	3	89	2	22118475
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACA PRKACG	1.94e-05	3	89	2	12842892
Pubmed	G-quadruplexes in the BAP1 promoter positively regulate its expression.	CHD2 CHD7	1.94e-05	3	89	2	29787736
Pubmed	VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.	PARD3B VIRMA	1.94e-05	3	89	2	37391589
Pubmed	Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability.	CHD2 CDH2	1.94e-05	3	89	2	31704914
Pubmed	XB130, a novel adaptor protein for signal transduction.	AFAP1L2 RASA1	1.94e-05	3	89	2	17412687
Pubmed	Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.	CHD2 CHD7	1.94e-05	3	89	2	30277262
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACA PRKACG	1.94e-05	3	89	2	19383776
Pubmed	Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.	PRKACA RYR2	1.94e-05	3	89	2	20615971
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MYT1L CYLD WAPL NRDC TYW1B SPIRE1 CHD2 CHD7 PJA1 KDM1B SNAP29 RAB11FIP3	2.06e-05	1084	89	12	11544199
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	PWP1 PRPF31 ABCF1 ERCC6 MAP1B CD2BP2 MCM10 VIRMA GTF3C5 TOP2B	2.49e-05	759	89	10	35915203
Pubmed	Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.	NDST3 NDST4	3.87e-05	4	89	2	22049073
Pubmed	Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites.	NDST3 NDST4	3.87e-05	4	89	2	12070138
Pubmed	Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments.	NRCAM NFASC	3.87e-05	4	89	2	11724816
Pubmed	Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling.	CDH2 CDH11	3.87e-05	4	89	2	18302981
Pubmed	Expression of four immunoglobulin superfamily adhesion molecules (L1, Nr-CAM/Bravo, neurofascin/ABGP, and N-CAM) in the developing mouse spinal cord.	NRCAM NFASC	3.87e-05	4	89	2	7706555
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACA PRKACG	3.87e-05	4	89	2	18385332
Pubmed	Structural and functional evolution of the L1 family: are four adhesion molecules better than one?	NRCAM NFASC	3.87e-05	4	89	2	10662501
Pubmed	Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis.	MAP1B ANP32A	3.87e-05	4	89	2	12807913
Pubmed	Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets.	PRKACA PRKACG	3.87e-05	4	89	2	15632203
Pubmed	A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis.	PRKACA PRKACG	3.87e-05	4	89	2	12721358
Pubmed	A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.	CYLD CHD2	3.87e-05	4	89	2	17606441
Pubmed	Differential regulation of TCR-mediated gene transcription by Vav family members.	SH3BP2 LCP2	3.87e-05	4	89	2	14757747
Pubmed	PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.	LCP2 SKAP2	3.87e-05	4	89	2	11301322
Pubmed	FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts.	CDH2 CDH11	3.87e-05	4	89	2	29642003
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PRPF31 ABCF1 WAPL ERCC6 SAP30BP CHD2 LCP2 MAP3K4	4.22e-05	497	89	8	36774506
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	PWP1 PRPF31 ABCF1 NRDC COPG1 CFDP1 RSF1 NUCKS1 HIC2	4.59e-05	653	89	9	33742100
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	PRPF31 CD2BP2 SAP30BP RSF1 CCDC97 TOP2B	4.69e-05	251	89	6	31076518
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CYLD PRPF31 HIVEP1 NRDC MAP1B COPG1 USP42 CD2BP2 PPP1R9A PRKACA KDM1B	5.19e-05	1005	89	11	19615732
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	WAPL MAP1B CD2BP2 SAP30BP CFDP1	5.22e-05	156	89	5	37108203
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	YIPF2 ZNF609 ZBTB48 RASA1 SAP30BP CFDP1 ANP32A NUCKS1 CHD2 ARHGEF10L RAB11FIP3	5.98e-05	1021	89	11	26760575
Pubmed	Local regulation of gene expression by lncRNA promoters, transcription and splicing.	CHD2 CDH2	6.44e-05	5	89	2	27783602
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACA PRKACG	6.44e-05	5	89	2	12972513
Pubmed	A role for cadherins in tissue formation.	CDH2 CDH11	6.44e-05	5	89	2	8898231
Pubmed	Cloning and expression analysis of a novel mesodermally expressed cadherin.	CDH2 CDH11	6.44e-05	5	89	2	7750649
Pubmed	Junctophilin Proteins Tether a Cav1-RyR2-KCa3.1 Tripartite Complex to Regulate Neuronal Excitability.	CACNA1D RYR2	6.44e-05	5	89	2	31461656
Pubmed	Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice.	PRKACA RYR2	6.44e-05	5	89	2	16481613
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACA PRKACG	6.44e-05	5	89	2	19483721
Pubmed	Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons.	CACNA1D RYR2	6.44e-05	5	89	2	31663850
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACA PRKACG	6.44e-05	5	89	2	21745501
Pubmed	Adhesive subdivisions intrinsic to the epithelial somites.	CDH2 CDH11	6.44e-05	5	89	2	10545229
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACA PRKACG	6.44e-05	5	89	2	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACA PRKACG	6.44e-05	5	89	2	19711044
Pubmed	Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4.	NDST3 NDST4	6.44e-05	5	89	2	11087757
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	PRPF31 SAP30BP POLR2H ANP32A MCM10 KLC4 GTF3C5	6.61e-05	390	89	7	17643375
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD PRPF31 HIVEP1 MAP1B ERCC6L SPIRE1 PARD3B KLC4 REEP3 VIRMA	7.15e-05	861	89	10	36931259
Pubmed	Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission.	WAPL ERCC6L PRKACA CLSPN GTF3C5	7.20e-05	167	89	5	25659891
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	PRPF31 WAPL CD2BP2 FLG2 GTF3C5 TOP2B	7.31e-05	272	89	6	31010829
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	PRPF31 ABCF1 MAP1B COPG1 VIRMA HNRNPLL GTF3C5 TOP2B MAP3K4	8.15e-05	704	89	9	29955894
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD NRCAM SV2A PPP1R9A HEATR5A VIRMA MAP3K4	8.62e-05	407	89	7	12693553
Pubmed	Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.	WAPL TOP2B	9.65e-05	6	89	2	31202577
Pubmed	Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12.	MYT1L NRCAM	9.65e-05	6	89	2	9598327
Pubmed	Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling.	NRCAM NFASC	9.65e-05	6	89	2	23897819
Pubmed	Regulation of Neural Circuit Development by Cadherin-11 Provides Implications for Autism.	CDH2 CDH11	9.65e-05	6	89	2	34135003
Pubmed	Genetic deletion of afadin causes hydrocephalus by destruction of adherens junctions in radial glial and ependymal cells in the midbrain.	NECTIN1 CDH2	9.65e-05	6	89	2	24236178
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACA PRKACG	9.65e-05	6	89	2	9837753
Pubmed	A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier.	NRCAM NFASC	9.65e-05	6	89	2	20188654
Pubmed	Characterization and significance of adhesion and junction-related proteins in mouse ovarian follicles.	NECTIN1 CDH2	9.65e-05	6	89	2	22321830
Pubmed	Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos.	IRX1 IRX4	9.65e-05	6	89	2	20408909
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACA PRKACG	9.65e-05	6	89	2	19197368
Pubmed	Iroquois homeobox 3 regulates odontoblast proliferation and differentiation mediated by Wnt5a expression.	IRX1 IRX4	9.65e-05	6	89	2	36773339
Pubmed	Organization of mouse Iroquois homeobox genes in two clusters suggests a conserved regulation and function in vertebrate development.	IRX1 IRX4	9.65e-05	6	89	2	11042145
Pubmed	Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast.	IRX1 IRX4	9.65e-05	6	89	2	10370142
Pubmed	Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex.	MAP1B SV2A PPP1R9A	9.99e-05	35	89	3	37758766
Interaction	PTGES3 interactions	ERCC6 NRCAM COPG1 PRKACG CHD7 KDM1B VIRMA GTF3C5 TOP2B ARHGEF10L HSP90AB3P	3.51e-06	437	89	11	int:PTGES3
Interaction	FGFR1 interactions	AFAP1 RASA1 COPG1 SH3BP2 NECTIN1 PRKACA KLC4 CDH2 VIRMA CDH11 SNAP29 HSP90AB3P	2.13e-05	632	89	12	int:FGFR1
Interaction	H3-3A interactions	PRPF31 WAPL HIVEP1 ERCC6 EML4 CFDP1 RSF1 CHD2 CHD7 KDM1B MCM10 GTF3C5 TOP2B	2.42e-05	749	89	13	int:H3-3A
Interaction	TERF2IP interactions	ZNF609 WAPL HIVEP1 SAP30BP CFDP1 RSF1 NUCKS1 CHD7 MCM10 CLSPN GTF3C5	3.12e-05	552	89	11	int:TERF2IP
Interaction	MECP2 interactions	PWP1 PRPF31 ABCF1 AFAP1 MAP1B USP42 CD2BP2 POLR2H NUCKS1 HIC2 CHD2 CHD7 KDM1B FLG2 HNRNPLL GTF3C5 TOP2B	4.15e-05	1287	89	17	int:MECP2
Interaction	CENPA interactions	PRPF31 HIVEP1 ERCC6 RSF1 CHD7 MCM10 VIRMA GTF3C5 TOP2B	4.34e-05	377	89	9	int:CENPA
Interaction	H2BC21 interactions	MAP1B USP42 CFDP1 RSF1 ANP32A NUCKS1 ARHGAP30 CHD7 KDM1B VIRMA GTF3C5 TOP2B	5.45e-05	696	89	12	int:H2BC21
Cytoband	5p15.3	IRX1 IRX4	1.66e-04	10	89	2	5p15.3
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	AFAP1 AFAP1L2 RASA1 SH3BP2 SKAP2	8.68e-04	206	65	5	682
GeneFamily	CD molecules\|Type II classical cadherins	CDH11 CDH18	9.68e-04	13	65	2	1186
GeneFamily	DNA helicases	CHD2 CHD7	1.67e-03	17	65	2	1167
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K15 MAP3K4	3.34e-03	24	65	2	654
GeneFamily	TALE class homeoboxes and pseudogenes	IRX1 IRX4	3.91e-03	26	65	2	526
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ABCF1 WAPL ERCC6 RASA1 MAP1B RSF1 ANP32A SPIRE1 HEATR5A CHD7 CLSPN CDH2 MAP3K4 LRRC23	3.81e-08	532	88	14	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	WAPL MAP1B RSF1 ANP32A HEATR5A CHD7 CDH2 MAP3K4	1.22e-05	259	88	8	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000	CACNA1D AFAP1L2 NRDC TRPV2 PRICKLE2 SPIRE1 PJA1 CDH11	3.93e-05	305	88	8	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ABCF1 MAP1B PPP1R9A ANP32A SPIRE1 CHD2 CHD7 CLSPN CDH2 TOP2B LRRC23	8.10e-05	654	88	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ABCF1 WAPL NRCAM RASA1 NRDC MAP1B USP42 ERCC6L RSF1 ANP32A SPIRE1 HIC2 CHD7 KDM1B MCM10 CLSPN CDH2	8.89e-05	1459	88	17	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ABCF1 AFAP1 MAP1B CHD2 CHD7 CLSPN KLC4 CDH2 VIRMA TOP2B SNAP29 RAB11FIP3	1.59e-04	831	88	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ABCF1 WAPL NRCAM RASA1 NRDC USP42 ERCC6L RSF1 ANP32A SPIRE1 HIC2 KDM1B MCM10 CLSPN CDH2	1.89e-04	1257	88	15	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	ABCF1 NRCAM MAP1B ANP32A CHD7 KDM1B CLSPN CDH2 HSP90AB3P	2.05e-04	493	88	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1	NRCAM FAM221A PPP1R9A NECTIN1 CHD7 CDH2 LRRC23	2.26e-04	295	88	7	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	MAP1B ERCC6L PPP1R9A RSF1 PJA1 CDH2 TOP2B RYR2	2.43e-04	397	88	8	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
ToppCell	COPD-Epithelial-PNEC\|World / Disease state, Lineage and Cell class	MYT1L NRCAM MAP1B PTPRN NFASC CDH2	8.38e-07	160	89	6	cdea93317b0ebb801ddbe73bca6149ce2c727f16
ToppCell	droplet-Pancreas\|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L CACNA1D MAP1B PTPRN NFASC MAP3K15	2.08e-06	187	89	6	5f4df092452d8672bda4059c794e099ba3f5a8fa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NDST3 AFAP1L2 NRCAM SPIRE1 MAP3K15 ARHGEF10L	2.08e-06	187	89	6	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D IL16 NFASC PARD3B CDH11 RYR2	2.35e-06	191	89	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D IL16 NFASC PARD3B CDH11 RYR2	2.42e-06	192	89	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D IL16 NFASC PARD3B CDH11 RYR2	2.49e-06	193	89	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1D PPP1R9A MTR PARD3B ARHGEF10L RAB11FIP3	2.49e-06	193	89	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	AFAP1L2 NRCAM MTR SPIRE1 MAP3K15 ARHGEF10L	2.49e-06	193	89	6	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1D NRCAM NFASC PARD3B CDH11 RYR2	2.64e-06	195	89	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1D NRCAM MAP1B RYR2 CDH18	2.72e-06	196	89	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D IL16 NFASC PARD3B CDH11 RYR2	2.72e-06	196	89	6	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1D NRCAM MAP1B RYR2 CDH18	2.89e-06	198	89	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1D NRCAM MAP1B RYR2 CDH18	2.89e-06	198	89	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1D NRCAM MAP1B RYR2 CDH18	2.89e-06	198	89	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D IL16 NFASC PARD3B CDH11 RYR2	2.89e-06	198	89	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L AMER2 NRCAM SV2A NFASC SPIRE1	3.06e-06	200	89	6	09fd3cb31bcc02444f1045f01fe39bce09359d35
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L AMER2 NRCAM NDST4 NFASC SPIRE1	3.06e-06	200	89	6	ddac952ad1d46021c2d17d816de9bc31730a0941
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D IL16 MAP1B NDST4 CDH11 RYR2	3.06e-06	200	89	6	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BP2 ARHGAP30 MAP3K15 LCP2 ARHGEF10L	1.54e-05	156	89	5	3f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRPV2 SPIRE1 HIC2 ARHGAP30 MCM10	1.54e-05	156	89	5	8349604bd801e20d33770f7d8243598c3756302b
ToppCell	facs-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BP2 ARHGAP30 MAP3K15 LCP2 ARHGEF10L	1.54e-05	156	89	5	69e6e8810d1738a66c9821910f41498931cf30cc
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERCC6L SH3BP2 ARHGAP30 MAP3K15 LCP2	1.64e-05	158	89	5	b35bab2b93d0af821bfae18a358eb7dddaf3860f
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERCC6L SH3BP2 ARHGAP30 MAP3K15 LCP2	1.64e-05	158	89	5	7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00
ToppCell	COPD-Epithelial-PNEC\|COPD / Disease state, Lineage and Cell class	MYT1L MAP1B PTPRN NFASC CDH2	1.69e-05	159	89	5	6018124980c55190928409f3bf41d846a118954a
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYT1L TRPV2 NFASC CDH2 RYR2	2.33e-05	170	89	5	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B NFASC MCM10 CDH11 SLC5A4	2.47e-05	172	89	5	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B NFASC MCM10 CDH11 SLC5A4	2.47e-05	172	89	5	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 TRPV2 ARHGAP30 LCP2 LRRC23	2.83e-05	177	89	5	7853430fb0d1a18d835e8956777e0616c5d7d412
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NDST4 MAP3K15 IRX1 TOP2B	2.83e-05	177	89	5	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	facs-Skin-Anagen-3m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 TRPV2 ARHGAP30 LCP2 LRRC23	2.83e-05	177	89	5	395f005f019aabb18738d3a10a04c37f216deda3
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 TRPV2 ARHGAP30 LCP2 LRRC23	2.83e-05	177	89	5	9a5bf67a801826d094f679dd2189b62296c9694f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NDST4 MAP3K15 IRX1 TOP2B	2.83e-05	177	89	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PTPRN NFASC SPIRE1 MAP3K15	2.91e-05	178	89	5	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	COPD-Epithelial-PNEC\|Epithelial / Disease state, Lineage and Cell class	MYT1L NRCAM PTPRN NFASC CDH2	2.99e-05	179	89	5	988d0853c391da1e5004f73f3678047418d3f6d3
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	WAPL NRDC CHD7 PJA1 CDH2	3.49e-05	185	89	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	AFAP1L2 NRCAM MAP1B NFASC RYR2	3.49e-05	185	89	5	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MAP1B NFASC PARD3B CDH11 RYR2	3.68e-05	187	89	5	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNA1D IL16 NFASC CDH11 RYR2	3.68e-05	187	89	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NDST3 AMER2 AFAP1L2 MAP1B CDH2	3.68e-05	187	89	5	0dee138738b65531ff134a125b92234b5d0a653c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L MAP1B PTPRN NDST4 RYR2	3.68e-05	187	89	5	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L MAP1B PTPRN NDST4 RYR2	3.68e-05	187	89	5	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L MAP1B PTPRN NDST4 RYR2	3.68e-05	187	89	5	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B ANP32A NDST4 MAP3K15 IRX1	3.77e-05	188	89	5	e99e3765b48392c987cf0c5ccbded0655637d7b7
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L AMER2 NRCAM MAP1B PTPRN	3.77e-05	188	89	5	bd091503f580dedab40e0996273101285d24b586
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	DUSP29 ERCC6L MCM10 CLSPN CDH2	3.87e-05	189	89	5	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MAP1B PTPRN NDST4 CDH18	3.97e-05	190	89	5	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MAP1B PTPRN NDST4 CDH18	3.97e-05	190	89	5	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MAP1B PTPRN NDST4 CDH18	3.97e-05	190	89	5	a9a705455019e28d655636de73b07540798f82e6
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	3.97e-05	190	89	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNA1D IL16 NFASC CDH11 RYR2	3.97e-05	190	89	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.07e-05	191	89	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Pancreas-Endocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PTPRN ANP32A NDST4 CDH2	4.07e-05	191	89	5	b3de0393d6510543533cd851e47a0f95739a0e4e
ToppCell	facs-Pancreas\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L CACNA1D MAP1B PTPRN MAP3K15	4.07e-05	191	89	5	d48e5f67d384226add7d7fb2a124954136e09a82
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYT1L MAP1B PTPRN CDH2 CDH18	4.07e-05	191	89	5	146cfd4daa2878536b4f381564c787919ad855a8
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYT1L MAP1B PTPRN CDH2 CDH18	4.07e-05	191	89	5	12ea07565dc0e62cade9fbab4a2d763e47a341e3
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PTPRN NDST4 MAP3K15 CDH2	4.07e-05	191	89	5	657297cd19d05a7e7bb74fc3a086fbd95f47aae4
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 EML4 PPP1R9A MTR PARD3B	4.17e-05	192	89	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 NRCAM SPIRE1 MAP3K15 ARHGEF10L	4.17e-05	192	89	5	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L AMER2 MAP1B CHD7 CDH2	4.17e-05	192	89	5	fe9297cb65234d9f511bab1a5dbf2679d5a4cd15
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	EML4 SH3BP2 ARHGAP30 LCP2 ARHGEF10L	4.17e-05	192	89	5	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRCAM MAP1B PPP1R9A ZNF428 CDH2	4.17e-05	192	89	5	1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 NRCAM SPIRE1 MAP3K15 ARHGEF10L	4.17e-05	192	89	5	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.17e-05	192	89	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1D MAP1B PRICKLE2 CDH11 RYR2	4.27e-05	193	89	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 EML4 PPP1R9A MTR PARD3B	4.27e-05	193	89	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYT1L MAP1B PTPRN CDH2 CDH18	4.27e-05	193	89	5	25b1e5a04724023918c8939109a92b35582d5e5c
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AFAP1 HIVEP1 EML4 MCM10 RAB11FIP3	4.38e-05	194	89	5	3211d89440a6f4a9b3d4cfb755890816944242ec
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AFAP1L2 NRCAM MAP1B CDH11 RYR2	4.38e-05	194	89	5	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1D IL16 NFASC CDH11 RYR2	4.49e-05	195	89	5	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L NRCAM MAP1B PTPRN TRPV2	4.49e-05	195	89	5	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1D IL16 NFASC CDH11 RYR2	4.49e-05	195	89	5	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	(08)_PNEC\|World / shred by cell type and Timepoint	MAP1B PTPRN SV2A NFASC MAP3K15	4.60e-05	196	89	5	2ee37155c03cd5009427a4bffe6c80ed2ac6939e
ToppCell	frontal_cortex-Neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYT1L MAP1B PTPRN SV2A PJA1	4.60e-05	196	89	5	de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NRCAM PPP1R9A MTR PARD3B ARHGEF10L	4.60e-05	196	89	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B NFASC CDH2 RYR2 ARHGEF10L	4.71e-05	197	89	5	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	AFAP1 NRCAM PRICKLE2 CDH11 RYR2	4.71e-05	197	89	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D IL16 MAP1B NDST4 CDH11	4.71e-05	197	89	5	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	MAP1B CFDP1 RSF1 CHD2 CLSPN	4.71e-05	197	89	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B NFASC CDH2 RYR2 ARHGEF10L	4.83e-05	198	89	5	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1D IL16 NRCAM CDH11 RYR2	4.83e-05	198	89	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L NRCAM MAP1B RYR2 CDH18	4.83e-05	198	89	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AFAP1L2 NRCAM MAP1B NFASC CCDC97	4.83e-05	198	89	5	882710bd6215e299257dd3df234292db9a2823ba
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	CACNA1D IL16 NFASC CDH11 RYR2	4.83e-05	198	89	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L MAP1B NFASC CHD7 CDH2	4.83e-05	198	89	5	dac7b68bb8f1c4d8aa7fdfada61f79956866e874
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1D MAP1B RYR2 CDH18	4.83e-05	198	89	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CACNA1D AFAP1 NRCAM CDH11 RYR2	4.94e-05	199	89	5	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B NFASC CDH2 RYR2 ARHGEF10L	4.94e-05	199	89	5	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L AMER2 NRCAM SV2A NFASC	5.06e-05	200	89	5	e9eb348a66011d8aace4331f84690ae27cb0d061
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 MAP1B NFASC CDH11 RYR2	5.06e-05	200	89	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D IL16 NFASC CDH11 RYR2	5.06e-05	200	89	5	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MYT1L CACNA1D MAP1B RYR2 CDH18	5.06e-05	200	89	5	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L AMER2 PTPRN SV2A NFASC	5.06e-05	200	89	5	458fb0f40c1720f1cacedf78c40bd059692bfc62
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D IL16 NFASC CDH11 RYR2	5.06e-05	200	89	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D IL16 NFASC CDH11 RYR2	5.06e-05	200	89	5	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron\|2m / Sample Type, Dataset, Time_group, and Cell type.	AMER2 AFAP1 MAP1B NFASC CHD7	5.06e-05	200	89	5	a581f1704a87b0390e1e2ff85053367d85247755
Drug	Niridazole [61-57-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	PRPF31 YIPF2 AFAP1 ZBTB48 ZFYVE26 HIC2 ZNF428 CFAP44	9.69e-07	197	88	8	5682_DN
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A	CYLD MAP1B SH3BP2 ZFYVE26 SKAP2 GTF3C5 ARHGEF10L RAB11FIP3	1.09e-06	200	88	8	1519_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	CYLD AFAP1 PRKACA CHD7 RYR2 LRRC23 RAB11FIP3	1.07e-05	195	88	7	4676_DN
Disease	autism spectrum disorder (implicated_via_orthology)	NDST3 NRCAM NDST4 CHD2 CHD7	9.43e-05	152	88	5	DOID:0060041 (implicated_via_orthology)
Disease	granulocyte colony-stimulating factor measurement	AFAP1 MAP1B ZNF428	1.43e-04	34	88	3	EFO_0008142
Disease	CHARGE syndrome (implicated_via_orthology)	CHD2 CHD7	1.83e-04	7	88	2	DOID:0050834 (implicated_via_orthology)
Disease	MASA syndrome (implicated_via_orthology)	NRCAM NFASC	1.83e-04	7	88	2	DOID:0060246 (implicated_via_orthology)
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	CDH2 RYR2	3.90e-04	10	88	2	DOID:0050431 (is_implicated_in)
Disease	forced expiratory volume	CACNA1D SV2A EML4 CFDP1 NUCKS1 PARD3B SKAP2 TOP2B RYR2	5.80e-04	789	88	9	EFO_0004314
Disease	sphingomyelin 18:1 measurement	MAP1B PARD3B	6.71e-04	13	88	2	EFO_0010394
Disease	body weight	MYT1L HIVEP1 NRCAM DUSP29 COPG1 PTPRN NUCKS1 PARD3B CHD7 VIRMA HNRNPLL	1.31e-03	1261	88	11	EFO_0004338
Disease	epilepsy (implicated_via_orthology)	NRCAM SV2A PRICKLE2 NFASC	1.46e-03	163	88	4	DOID:1826 (implicated_via_orthology)
Disease	Autism Spectrum Disorders	MYT1L CHD2 RYR2	2.12e-03	85	88	3	C1510586
Disease	systemic scleroderma	MYT1L CHD7 FLG2	2.12e-03	85	88	3	EFO_0000717
Disease	Neurodevelopmental Disorders	MYT1L PARD3B CHD2	2.74e-03	93	88	3	C1535926
Disease	alcohol use disorder (implicated_via_orthology)	RASA1 PRKACA PRKACG RYR2	2.80e-03	195	88	4	DOID:1574 (implicated_via_orthology)
Disease	azoospermia (implicated_via_orthology)	NDST3 NDST4	2.94e-03	27	88	2	DOID:14227 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEEEEGGESKADDPY	ABCF1	236	Q8NE71
GGEEMASPDEVDDTY	AMER2	421	Q8N7J2
SYSEDSGEEAKPEVE	ARHGEF10L	176	Q9HCE6
SYESYDEEEEDGKGK	AFAP1	121	Q8N556
QADTGGDDSDEDYEK	SH3BP2	436	P78314
ESYDEEDGSKGKSAP	AFAP1L2	146	Q8N4X5
DGYDRDDKEAPDSDA	ANP32A	146	P39687
DDKEAPDSDAEGYVE	ANP32A	151	P39687
PDSDAEGYVEGLDDE	ANP32A	156	P39687
PFKDGETLEGSDAEE	CHD7	2946	Q9P2D1
FTKGEGSYLEEDSDE	CFAP44	51	Q96MT7
PEAEGDSEGEESEYF	ERCC6	361	Q03468
GKFYHTGTEEEDEGD	NDST3	351	O95803
GTVDEGDSLDGPEYE	RASA1	151	P20936
GDSLDGPEYEEEEVA	RASA1	156	P20936
EDYGEGSEAELSPET	RAB11FIP3	391	O75154
DEKRPYAEGEEEEGG	IRX4	216	P78413
KTEEGEIDYSAEEGE	HNRNPLL	26	Q8WVV9
SDDIKPRSEDYDAGG	KIAA1107	746	Q9UPP5
PEAEGDSEGEESEYF	ERCC6	361	P0DP91
YDEDGHTSEEKEGDA	KLC4	156	Q9NSK0
DEAPFQEKDSGSDED	NUCKS1	121	Q9H1E3
DKSYDGPEEIEADGL	PARD3B	786	Q8TEW8
EEDEEDTPGHKSGYR	FLG2	116	Q5D862
EDSPEGYEKEGLGDR	PTPRN	306	Q16849
GPGDTSNFDDYEEEE	PRKACA	321	P17612
AGFEESSETGDYEEK	MAP1B	931	P46821
KEDDGTFGEYSDAED	NRCAM	1216	Q92823
DVGSDEEDDSKEYGE	HSP90AB3P	231	Q58FF7
GKDGDFDYSTVDDNP	CCDC97	296	Q96F63
TEEGEDYRKEGEEFP	LRRC23	26	Q53EV4
APGEKGEEKEEDEDY	ISM2	261	Q6H9L7
GEEKEEDEDYPSEDI	ISM2	266	Q6H9L7
EYTEGLTEAKEDDDG	IL16	1056	Q14005
DGESYTEEADDGETG	MCM10	51	Q7L590
KFYHTGTEEEDEGDD	NDST4	351	Q9H3R1
PKYEEEEEEEGGLST	PRICKLE2	501	Q7Z3G6
PKEEDGSFDYSDEDN	NFASC	1261	O94856
EEEDDDDGGSSKYDI	CD2BP2	51	O95400
TSEEDEDYVPSGGEY	CFDP1	11	Q9UEE9
DDGAAEKETLPEFGE	HEATR5A	1651	Q86XA9
GPGDASNFDDYEEEE	PRKACG	321	P22612
ETTDEDEDGGSEKKY	KDM1B	36	Q8NB78
EEGEEEDYCTPGAFE	DUSP29	26	Q68J44
DPSGDFDTEKDEGEI	CHD2	291	O14647
PEEEEGEGYEEPDSE	CD19	401	P15391
GEGYEEPDSEEDSEF	CD19	406	P15391
ITYDDEGGGEEDTEA	CDH11	661	P55287
VTYDDEGGGEEDTEA	CDH18	656	Q13634
DPTTGETDDEGYEDE	COPG1	736	Q9Y678
ESEEGSGDLGEPLYE	EML4	941	Q9HC35
EDDDTALESDYAGPG	CYLD	206	Q9NQC7
EDDGGKLFTPEEYEE	FAM221A	26	A4D161
YSEADEEEEEEEGKP	RSF1	1281	Q96T23
GIGDEIEDPAGDEYE	RYR2	4826	Q92736
GYSDEEPDPGRDEED	CACNA1D	2136	Q01668
YESSEPADFKVDEDG	CDH2	71	P19022
DSSEAKGPEDYPEEG	ERCC6L	1116	Q2NKX8
GEASKYTEEDPSGET	ERCC6L	1136	Q2NKX8
EPGGDEYTDEKEKEI	ARHGAP30	736	Q7Z6I6
KGNEPEYEGDDTEGE	MAP3K4	436	Q9Y6R4
EGVDKDMDEAEEGYP	MAP3K15	1146	Q6ZN16
AYETGSGGAEEEAED	HIC2	476	Q96JB3
GEDEFVPSDGLDKDE	TOP2B	1406	Q02880
KGDAEDGEEYDDPFA	SKAP2	66	O75563
FGSDTEGDPEKAEDD	IRX1	206	P78414
GVEELSKAYEDDGDD	MTR	1106	Q99707
KSYNPFDDDGEDEGA	SNAP29	6	O95721
EETDDGVEEDYPEKS	SLC5A4	581	Q9NY91
DGDEKTDEEAEGPYS	REEP3	196	Q6NUK4
EEDDDDDFPAPSDGY	SV2A	51	Q7L0J3
SGSDVGSEDEYDGEE	CLSPN	1061	Q9HAW4
EPAETGGYASLEEDD	ZNF428	6	Q96B54
GGYASLEEDDEDLSP	ZNF428	11	Q96B54
DLDKYDEEGDPDAET	PWP1	96	Q13610
QVEDDGDGDYMSEPE	ZBTB48	236	P10074
YSEDEDSEGEEKSDG	SOX13	601	Q9UN79
PYGAESSEDSDEESK	USP42	606	Q9H9J4
DEGYEAAEEGLGDED	SPIRE1	171	Q08AE8
LEEAAEEEEGGSYGE	PRPF31	11	Q8WWY3
EEEEGGSYGEEEEEP	PRPF31	16	Q8WWY3
GSYGEEEEEPAIEDV	PRPF31	21	Q8WWY3
TDDDSKPEADGDSEY	ZNF609	521	O15014
FYTSDEEDDDGSPGT	TIGD4	451	Q8IY51
SPPKEDEDGASEENY	TRPV2	741	Q9Y5S1
EESTGDPFGFDSDDE	WAPL	66	Q7Z5K2
GKYELEEDGTPSSED	NRDC	1091	O43847
EDGTLDDGEYNPTDD	POLR2H	66	P52434
EEKGGLVSDAYGEDD	SAP30BP	36	Q9UHR5
GKEQLTYESGEDEED	GTF3C5	476	Q9Y5Q8
SGGSYGAEDEVEEES	YIPF2	46	Q9BWQ6
YGADDSEEEGAGPVE	PJA1	121	Q8NG27
EGEGDDGYEQISSDE	VIRMA	291	Q69YN4
PEDYAEDDDIEGKSP	ZFYVE26	596	Q68DK2
ERSGYDLEESDGPDE	HIVEP1	2171	P15822
KEEEPFESSSEEEFG	TYW1B	241	Q6NUM6
DGEDDGDYESPNEEE	LCP2	121	Q13094
EGEEYSEDNDEPGDE	MYT1L	106	Q9UL68
TGEYATDEEEDEVGP	PPP1R9A	631	Q9ULJ8
LGGSSYEEEEEEEEG	NECTIN1	431	Q15223